InnoCan Pharma Corporation (CSE:INNO)
2.500
-0.180 (-6.72%)
Jun 30, 2026, 11:11 AM EST
InnoCan Pharma Market Cap
InnoCan Pharma has a market cap or net worth of CAD 11.25 million as of July 1, 2026. Its market cap has decreased by -80.62% in one year.
Market Cap
11.25M
Enterprise Value
7.78M
Revenue
35.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.50
Market Cap Chart
Since September 25, 2019, InnoCan Pharma's market cap has increased from 1.06M to 11.25M, an increase of 958.54%. That is a compound annual growth rate of 41.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 11.25M | -62.69% |
| Dec 30, 2025 | 30.14M | -49.98% |
| Dec 31, 2024 | 60.26M | -27.47% |
| Dec 29, 2023 | 83.08M | 54.74% |
| Dec 30, 2022 | 53.69M | -72.99% |
| Dec 31, 2021 | 198.79M | 218.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Loblaw Companies | 74.92B |
| Dollarama | 51.78B |
| George Weston | 38.52B |
| Metro | 19.04B |
| Global Education Communities | 17.77M |
| HYTN Innovations | 17.26M |
| Big Rock Brewery | 16.96M |
| THS Maple Holdings | 10.26M |